Page last updated: 2024-09-03

vadimezan and cyproheptadine

vadimezan has been researched along with cyproheptadine in 3 studies

Compound Research Comparison

Studies
(vadimezan)
Trials
(vadimezan)
Recent Studies (post-2010)
(vadimezan)
Studies
(cyproheptadine)
Trials
(cyproheptadine)
Recent Studies (post-2010) (cyproheptadine)
272161012,297262201

Protein Interaction Comparison

ProteinTaxonomyvadimezan (IC50)cyproheptadine (IC50)
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)0.0024
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)0.564
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.035
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.016
5-hydroxytryptamine receptor 2CRattus norvegicus (Norway rat)0.0031
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.0038
Alpha-2A adrenergic receptorHomo sapiens (human)0.283
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.016
D(2) dopamine receptorHomo sapiens (human)0.164
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)0.0031
Alpha-2B adrenergic receptorHomo sapiens (human)0.038
Alpha-2C adrenergic receptorHomo sapiens (human)1.275
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.122
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.046
D(1A) dopamine receptorHomo sapiens (human)0.158
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.564
Histamine H2 receptorHomo sapiens (human)0.198
Alpha-1D adrenergic receptorHomo sapiens (human)0.107
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.001
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.0024
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)0.122
5-hydroxytryptamine receptor 2BRattus norvegicus (Norway rat)0.0031
Histamine H1 receptorHomo sapiens (human)0.0037
D(3) dopamine receptorHomo sapiens (human)0.048
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.0094
5-hydroxytryptamine receptor 6Homo sapiens (human)0.281
D(2) dopamine receptorRattus norvegicus (Norway rat)0.14
Histone-lysine N-methyltransferase SETD7Homo sapiens (human)2.2

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baguley, BC; Cole, G; Li, Z; Thomsen, LL1
Baguley, BC; Ching, LM; Kestell, P; Philpott, M; Zhao, L; Zhuang, L1
Ching, LM; Kestell, P; Paxton, JW; Tingle, MD; Zhou, S1

Other Studies

3 other study(ies) available for vadimezan and cyproheptadine

ArticleYear
Serotonin involvement in the antitumour and host effects of flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.
    Cancer chemotherapy and pharmacology, 1993, Volume: 33, Issue:1

    Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Cyproheptadine; Flavonoids; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Necrosis; Nitrates; Nitric Oxide; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones

1993
Effects of the serotonin receptor antagonist cyproheptadine on the activity and pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
    Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:6

    Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Cyproheptadine; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Female; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Serotonin Antagonists; Tissue Distribution; Xanthenes; Xanthones

2001
A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomide.
    Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:6

    Topics: Animals; Antineoplastic Agents; Cyproheptadine; Diclofenac; Drug Interactions; Glucuronides; Hydroxylation; Male; Mice; Microsomes, Liver; Rats; Rats, Wistar; Thalidomide; Xanthenes; Xanthones

2001